Currently submitted to: JMIR Preprints
Date Submitted: Aug 19, 2020
Open Peer Review Period: Aug 19, 2020 - Aug 4, 2021
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Convalescent Plasma Therapy: A Century Old Technique for COVID-19
ABSTRACT
It has been proved that the current COVID-19 pandemic can be loosely bound to its predecessor outbreaks i.e. SARS and MERS. No vaccine or approved treatment is available for either coronavirus. At present, COVID-19 has infected 2,436,743 people in over 200 countries with unprecedented transmission rate. Healthcare workers in China initiated treatment of clinically worsening COVID-19 patients with a traditional method of passive immunity i.e. transfusion of plasma recovered from COVID-19 recuperated patients. According to available medical data, this technique is routinely favored by the World Health Organization (WHO) and has been in use since 1890 for combatting newly emerging infectious diseases, most commonly of a viral origin. Exploration of studies carried out on Convalescent Plasma and its effectiveness in the past steered our path to theorize the possibility of reducing mortality with convalescent plasma therapy and put together reviewed evidence to support our rallying efforts for enlisting this in the official treatment protocol of COVID-19.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.